Efficacy of Hushen Gujing (HSGJ) in preventing chronic allograft nephropathy in rats.
- Author:
Xiao-hui TIAN
1
;
Wu-jun XUE
;
Zhi-yong WANG
;
Qing-fa ZHOU
;
Yin-sheng ZHANG
;
Xiao-ming DING
;
Pu-xun TIAN
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Chronic Disease; Drugs, Chinese Herbal; therapeutic use; Glomerulonephritis; etiology; immunology; prevention & control; Graft Rejection; drug therapy; Immunosuppressive Agents; therapeutic use; Kidney Transplantation; adverse effects; Random Allocation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous
- From: China Journal of Chinese Materia Medica 2005;30(17):1349-1352
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the effect of HSGJ on chronic allograft nephropathy (CAN) using standard rat model of CAN.
METHODRenal transplantation was performed with Fisher rats as donors and Lewis rats as recipients. All the recipients were randomly divided into control group and medication groups (high and low dosage of HSGJ, fed every other day). After 16 weeks of treatment, renal function and the histological alteration of CAN were measured. The expression of the TGFbeta1 mRNA in the allograft was evaluated by real-time PCR.
RESULTThe content of 24 h urine protein and the level of serum creatinine in the medication groups were significantly decreased (P < 0.01) as compared with control group, whereas the creatinine clearance was increased (P < 0.01). The degree of glomerular sclerosis and the Banff score of medication groups were lower than the control group respectively (P < 0.01), in consistent with decreased expression of the TGF 1mRNA.
CONCLUSIONHSGJ can prevent the chronic allograft nephropathy and the mechanism may be related with its influence on the expression of the TGFbeta1.
